Allergy is a hypersensitivity disorder of the immune system, where our body hyper reacts to a normally harmless substance. People who have allergies are often sensitive to more than one substance. Going by that definition any substance is a potential allergen.
Allergy is a Type I hypersensitivity reaction, immunologic in nature, occurring within minutes after the combination of antigen and antibody bound to a mast cell in an individual previously sensitized to the antigen. It could be a systemic or localized reaction depending on the antigen (allergen) involved.
Most allergic hypersensitive reactions are a topic in nature. Atopy is a personal and/or familial tendency, usually in childhood or adolescence, to become sensitized and produce IgE antibodies in response to ordinary exposure to allergens, usually proteins. As a consequence these individuals can develop typical symptoms of asthma, rhino conjunctivitis or eczema.
Allergen exposure is a prerequisite for sensitization in a topic individuals. IgE antibodies can be detected very early in the blood, even before symptoms become evident; hence IgE sensitization is a “risk marker” for developing allergy.
No special preparation is needed for Allergy Eczema Panel Fluorescence Assay Skin. Inform your doctor if you are on any medications or have any underlying medical conditions or allergies before undergoing Allergy Eczema Panel Fluorescence Assay Skin.
Immunocap testing results:
• Show patients’ baseline IgE antibody levels
• Evaluate which allergens are the most probable for causing symptoms
• Evaluate if specific immunotherapy (SIT) is an option
• Follow changes over time to:
— reflect the effect of and compliance with allergen avoidance/reduction
— optimize medical strategies
— evaluate tolerance development (food allergy, SIT)
— avoid unnecessary food challenges
Allergy Eczema Panel Fluorescence Assay Skin is done using Fluorescence
Assay method on a Skin sample. This procedure involves a skin test where small
amount of allergen is introduced into the patient.
Immunocap is a Fluorescent enzyme immunoassay which is by gold standard in
in-vitro allergy testing worldwide. It can be performed irrespective of:
— Disease activity/or severity
— Antihistamine medication
The normal result for Allergy Eczema Panel Fluorescence Assay Skin for Allergic
Skin Reaction is A wheal and flare reaction of atleast 3mm indicates that the
patient is allergic to the substance for Unisex gender and for All age groups.
Allergy - Eczema Panel
All age groups